Product Information

VALSARTAN 40 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0973 per EA under NDC 43547036709. Its NADAC has been published 164 times since Jul 5, 2023.

FDA first approved this application on Jun 9, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the valsartan market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for VALSARTAN 40 MG TABLET has been published 164 times since Jul 5, 2023, and over the history we have for it it has declined 36.8%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.